Dopaminergic inhibition of striatal GABA release after 6-hydroxydopamine

Brain Research

Volumn 738, Issue 1, 1996, Pages 142-145

  Harsing, Laszlo G ^a,b   Zigmond, Michael J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Institute for Drug Research Budapest   (Hungary)

Author keywords

6 hydroxydopamine; brain slice; dopamine; GABA release; neostriatum; Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; NIPECOTIC ACID; OXIDOPAMINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030605165     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00956-0     Document Type: Article

References (34)

1. Abercrombie E.D., Bonatz A.E., Zigmond M.J. Effects of 1-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525:1990;36-44.
2. Agid Y., Guyenet P., Glowinski J., Beaujouan J.C., Javoy F. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat. Brain Res. 86:1975;488-492.
3. Anton A.H., Sayre D.R. A study of the factors affecting the aluminum oxide-trihydroxyindole procedures for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 138:1962;360-374.
4. 3H]GABA release from striatal slices: evidence for a calcium-independent process via the GABA uptake system. Neuroscience. 27:1988;563-570.
5. Bernath S., Zigmond M.J. Dopamine may influence striatal GABA release via three separate mechanisms. Brain Res. 476:1989;373-376.
6. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological, and neurochemical correlations. J. Neurol. Sci. 20:1973;415-455.
7. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-due binding. Anal. Biochem. 72:1976;248-254.
8. Chesselet, M.-F., Mercugliano, M., Soghomonian, J.-J., Salin, P., Qin, Y. and Gonzales, C., Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. In G.W. Arbuthnott and P.C. Emson (Eds.), Chemical Signalling in the Basal Ganglia, Progress in Brain Research, Elsevier Science Publishers B.V., Amsterdam, 1993, pp. 143-154.
9. 3H]spiroperidol binding. Eur. J. Pharmacol. 56:1979;277-281.
10. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
11. 2 dopamine receptor stimulation in the dorsal caudate putamen. Neuroscience. 19:1986;1109-1117.
12. 1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Res. 590:1992;305-310.
13. Harsing L.G. Jr., Sershen H., Lajtha A. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization. J. Neurochem. 59:1992;48-54.
14. 2 interactions and non-synaptic influences, Neuroscience, (1996) in press.
15. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195:1980;123-137.
16. Iversen L.L., Kelly J.S. Uptake and metabolism of γ-aminobutyric acid by neurones and glial cells. Biochem. Pharmac. 24:1975;933-938.
17. 3H-mazidol autoradiography. J. Neurosci. 5:1985;1513-1521.
18. Keller R.W., Oke A., Mefford I., Adams R. Liquid chromatographic analysis of catecholamines: routine assay for regional brain mapping. Life Sci. 19:1976;995-1004.
19. Liang L.P., Zigmond M.J. Dopamine synthesis in neostriatal slices after intraventricular 6-hydroxydopamine. Soc. Neurosci. Abstr. 19:1993;401.
20. MacKenzie R.G., Stachowiak M.K., Zigmond M.J. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. Eur. J. Pharmacol. 168:1989;43-52.
21. Marshall J.F., Navarette R., Joyce J.N. Decreased striatal D-1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis. Brain Res. 493:1989;247-257.
22. Metcalf B.W. Inhibitors of GABA metabolism. Biochem. Pharmacol. 28:1979;1705-1712.
23. Nisenbaum E.S., Stricker E.M., Zigmond M.J., Berger T.W. Long-term effects of dopamine-depleting brain lesions on spontaneous activity of Type II striatal neurons: relation to behavioral recovery. Brain Res. 398:1986;221-230.
24. Onn S.P., Berger T.W., Stricker E.M., Zigmond M.J. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: Histochemical and neurochemical analysis. Brain Res. 376:1986;8-19.
25. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450:1988;209-224.
26. Snyder G.L., Keller R.W. Jr., Zigmond M.J. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J. Pharmacol. Exp. Ther. 253:1990;867-876.
27. Stachowiak M.K., Keller R.W. Jr., Stricker E.M., Zigmond M.J. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J. Neurosci. 7:1987;1648-1654.
28. Szerb J.C. Effect of nipecotic acid, a γ-aminobutyric acid transport inhibitor, on the turnover and release of γ-aminobutyric acid in the rat cerebral cortex. J. Neurochem. 39:1982;850-858.
29. Uretsky N.J., Iversen L.L. Effects of 6-hydroxydopamine on catecholamine containing neurons in rat brain. J. Neurochem. 17:1970;269-278.
30. 2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.
31. Zhang W.Q., Tilson H.A., Nanry K.P., Hudson P.M., Hong J.S., Stachowiak M.K. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res. 461:1988;335-342.
32. Zigmond M.J., Stricker E.M. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science. 182:1973;717-720.
33. Zigmond, M.J. and Stricker, E.M., Behavioral and neurochemical effects of central catecholamine depletion: A possible model for `subclinical' brain damage. In I. Hanin and E. Usdin (Eds.), Animal Models in Psychiatry and Neurology, Pergamon Press, New York, 1977, pp. 415-429.
34. Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A. and Stricker, E.M., Compensatory responses to partial loss of dopaminergic neurons: studies with 6-hydroxydopamine. In J.S. Schneider and M. Gupta (Eds.), Current Concepts in Parkinson's Disease Research, Hogrefe and Hubert Publishers, Toronto, Ontario, 1993, pp. 99-140.